SRNE News and Press, Sorrento Therapeutics Inc. From 09/04/20

The following slide deck was published by Sorrento Therapeutics, Inc. in conjunction with this Read more ...

Sorrento Therapeutics ( SRNE -14.7% ) is under pressure, albeit on below-average volume, following yesterday's corporate overview by chief Henry Ji, Ph.D. Highlights: More news on: Sorrento Therapeutics, Inc., Healthcare stocks news, Read more ...

Do you like to go against the grain? Buying shares of heavily shorted stocks could be right up your alley. These are stocks that some investors are so pessimistic about that they borrow shares to sell. Their bet is that the stock will fall so they can buy at a lower price to give the shares back...

Shares of Sorrento Therapeutics (NASDAQ: SRNE) were trading 5.5% lower as of 12:22 p.m. EDT on Wednesday. The morning's declines came after the company announced earlier that it had completed its acquisition of SmartPharm Therapeutics on Tuesday. Investors have known about Sorrento's plans...

SAN DIEGO and BOSTON, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) and SmartPharm Therapeutics, Inc. (“SmartPharm”) announced today that Sorrento has completed the acquisition of SmartPharm, a gene-encoded protein ther...

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

Sorrento Therapeutics (NASDAQ: SRNE) is one of those stocks that's kind of like a lightning rod. That's apparent from the fact that over 22% of the biotech's outstanding shares were sold short as of Aug. 14, 2020. On the other hand, there are also many investors who feel strongly optimistic ...

After predicting that Moderna ( MRNA ) would have trouble trading at $100 a few months ago and then going nowhere next , readers may think this update will turn bearish. It will not. Investors should have expected the bearish selling on Moderna, Novavax ( NVAX ), and especially Sorrento...

Cocrystal Pharma (NASDAQ: COCP )   -25%  after raising "bought deal" offering to $15M. More news on: Cocrystal Pharma, Inc., SunPower Corporation, Quidel Corporation, Stocks on the move, , Read more ...

Most companies don't comment on outside reports. Sorrento Therapeutics ' (NASDAQ: SRNE) President and CEO Henry Ji even says that's generally the biotech's policy. Then he went off on short sellers in an interview posted in a tweet by RagingBull yesterday afternoon. "I am giving them a fa...